Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFE LAAC CKD: Antiplatelet therapy after LAAC in dialysis patients
NCT05660811Phase 4Recruiting
- Sponsor
- National Institute of Cardiology
- Start
- Sep 2022
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel, aspirin in Atrial fibrillation (AFib), sponsored by National Institute of Cardiology. Started Sep 2022; status: recruiting.
02
Drugs
clopidogrelaspirin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05660811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05660811.